Janney Starts Marinus Pharmaceuticals (MRNS) at Buy
Tweet
Share
E-mailGet Alerts MRNS Hot Sheet
Price: $0.55 --0%
Rating Summary:
6 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 35
Rating Summary:
6 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 35
Join SI Premium – FREE
Janney Montgomery Scott initiated coverage on Marinus Pharmaceuticals (NASDAQ: MRNS) with a Buy rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Marinus Pharmaceuticals click here. For more ratings news on Marinus Pharmaceuticals click here.
Shares of Marinus Pharmaceuticals closed at $8.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts AbCellera Biologics (ABCL) at Overweight, 'feedback bodes well overall'
- Goldman Sachs Starts Adeptus Biotechnologies Corp. (ADPT) at Buy
- Jefferies Resumes Array Technologies (ARRY) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
